Caribou Biosciences, Inc. 8-K Filing: Key Insights and Securities Info

$CRBU
8-K
Filed on: 2025-01-13
View Source
Caribou Biosciences, Inc. 8-K Filing: Key Insights and Securities Info

Based on the provided section of the financial report, here are the key insights:

  1. Company Information:
  • Name: Caribou Biosciences, Inc.
  • CIK Number: 0001619856
  • State of Incorporation: Delaware (DE)
  • Tax ID: 45-3728228
  • Address: 2929 7th Street, Suite 105, Berkeley, CA 94710
  • Phone Number: 510-982-6030
  1. Filing Details:
  • Filing Type: Form 8-K
  • Filing Date: January 12, 2025
  • Period Covered: January 12, 2025
  • SEC File Number: 001-40631
  1. Securities Information:
  • Common Stock: Par value of $0.0001 per share
  • Ticker Symbol: CRBU
  • Exchange: NASDAQ
  1. XML and XBRL Information:
  • The report is formatted in XBRL (eXtensible Business Reporting Language) for regulatory purposes, which allows for easier data analysis and interpretation.
  • A schema reference is provided, indicating the specific XBRL definitions used in this filing.

Summary:

This section of the report provides essential details about Caribou Biosciences, Inc., including its basic corporate information, the nature of the filing (Form 8-K), and its securities listed on NASDAQ. The filing is structured in XBRL format, which is important for compliance and makes it easier for investors and analysts to access the data.

You May Also Like